TY - JOUR
T1 - Transformation of FL into DLBCL with a PMBL gene expression signature
AU - Loveday, Tristan
AU - Duns, Gerben
AU - Rimsza, Lisa M.
AU - Rech, Karen L.
AU - Cook, James R.
AU - Robetorye, Ryan S.
AU - Rosenthal, Allison C.
AU - Ramsower, Colleen A.
AU - Yip, Tameson K.
AU - McKinney, Catherine L.
AU - Swerdlow, Steven H.
AU - Bhavsar, Shweta
AU - Steidl, Christian
AU - Gibson, Sarah E.
N1 - Funding Information:
Research reported in this publication was supported by National Cancer Institute grant U01CA57581 (L.M.R.).
Publisher Copyright:
© 2023 by The American Society of Hematology.
PY - 2023/3/28
Y1 - 2023/3/28
N2 - We investigated the clinicopathologic features of 5 follicular lymphomas (FLs) that transformed (tFL) morphologically to diffuse large B-cell lymphomas (DLBCLs) and had a primary mediastinal large B-cell lymphoma (PMBL)-like gene expression profile (tFL-PMBLsig-pos). None of the tFL-PMBLsig-pos cases arose in the mediastinum, all cases tested had a germinal center B-cell phenotype, 20% were CD30+, 60% CD23+, 80% MAL+, 20% CD200+, and 0% CD273/PDL2+. Whole-exome sequencing detected alterations in genes associated with both FL/DLBCL (CREBBP, KMT2C, KMT2D, ARID1A, HIST1 members, and TNFRSF14) and PMBL (JAK-STAT pathway genes, B2M, and CD58). Copy number (CN) analysis detected gains/amplification of REL and STAT6 in 60%, gains of SOCS1 in 40%, and gains of chromosome 16, including IL4R, in 40% of the cases. CN gains/amplification of BCL6 and MYC and loss of TNFRSF14 and TNFAIP3 were identified in 20% of the cases. Three of 5 cases lacked a BCL2 rearrangement. Despite having some features that are less common in DLBCL (MAL and CD23 expression and JAK-STAT activation), these tFL-PMBLsig-pos cases lack the most characteristic CN alteration seen in PMBL (9p24.1 gain/amplification). This cohort expands the biologic heterogeneity of tFL, illustrating a subset with gene expression and some genetic features reminiscent of PMBL, with potential treatment implications that include the use of novel targeted therapies.
AB - We investigated the clinicopathologic features of 5 follicular lymphomas (FLs) that transformed (tFL) morphologically to diffuse large B-cell lymphomas (DLBCLs) and had a primary mediastinal large B-cell lymphoma (PMBL)-like gene expression profile (tFL-PMBLsig-pos). None of the tFL-PMBLsig-pos cases arose in the mediastinum, all cases tested had a germinal center B-cell phenotype, 20% were CD30+, 60% CD23+, 80% MAL+, 20% CD200+, and 0% CD273/PDL2+. Whole-exome sequencing detected alterations in genes associated with both FL/DLBCL (CREBBP, KMT2C, KMT2D, ARID1A, HIST1 members, and TNFRSF14) and PMBL (JAK-STAT pathway genes, B2M, and CD58). Copy number (CN) analysis detected gains/amplification of REL and STAT6 in 60%, gains of SOCS1 in 40%, and gains of chromosome 16, including IL4R, in 40% of the cases. CN gains/amplification of BCL6 and MYC and loss of TNFRSF14 and TNFAIP3 were identified in 20% of the cases. Three of 5 cases lacked a BCL2 rearrangement. Despite having some features that are less common in DLBCL (MAL and CD23 expression and JAK-STAT activation), these tFL-PMBLsig-pos cases lack the most characteristic CN alteration seen in PMBL (9p24.1 gain/amplification). This cohort expands the biologic heterogeneity of tFL, illustrating a subset with gene expression and some genetic features reminiscent of PMBL, with potential treatment implications that include the use of novel targeted therapies.
UR - http://www.scopus.com/inward/record.url?scp=85152907740&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85152907740&partnerID=8YFLogxK
U2 - 10.1182/bloodadvances.2022007360
DO - 10.1182/bloodadvances.2022007360
M3 - Article
C2 - 36240289
AN - SCOPUS:85152907740
SN - 2473-9529
VL - 7
SP - 893
EP - 899
JO - Blood advances
JF - Blood advances
IS - 6
ER -